Literature DB >> 20478733

Improvement of cognition, a potential benefit of anti-TNF therapy in elderly patients with rheumatoid arthritis.

Yi-Ming Chen, Hsin-Hua Chen, Jong-Liang Lan, Der-Yuan Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20478733     DOI： 10.1016/j.jbspin.2010.01.017

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  13 in total

1.  Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis.

Authors:  Richard C Chou; Michael Kane; Sanjay Ghimire; Shiva Gautam; Jiang Gui
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

2.  Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

3.  Effects of centrally administered etanercept on behavior, microglia, and astrocytes in mice following a peripheral immune challenge.

Authors:  Marie Lou Camara; Frances Corrigan; Emily J Jaehne; Magdalene C Jawahar; Helen Anscomb; Bernhard T Baune
Journal:  Neuropsychopharmacology       Date:  2014-08-08       Impact factor: 7.853

Review 4.  Drug repositioning for Alzheimer's disease.

Authors:  Anne Corbett; James Pickett; Alistair Burns; Jonathan Corcoran; Stephen B Dunnett; Paul Edison; Jim J Hagan; Clive Holmes; Emma Jones; Cornelius Katona; Ian Kearns; Patrick Kehoe; Amrit Mudher; Anthony Passmore; Nicola Shepherd; Frank Walsh; Clive Ballard
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

5.  Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans.

Authors:  Chunlei Zheng; Nathanael R Fillmore; Jaime Ramos-Cejudo; Mary Brophy; Ricardo Osorio; Mark E Gurney; Wei Qiao Qiu; Rhoda Au; George Perry; Maureen Dubreuil; Shu G Chen; Xin Qi; Pamela B Davis; Nhan Do; Rong Xu
Journal:  Alzheimers Dement       Date:  2021-09-27       Impact factor: 16.655

6.  Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Krishnan M Dhandapani; Hedy Folkersma; Roger F Butterworth; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

7.  Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline?

Authors:  Pilar Lavielle; Juan O Talavera; Nancy Reynoso; Marissa González; Rita A Gómez-Díaz; Miguel Cruz; Felipe Vázquez; Niels H Wacher
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

Review 8.  Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2016-09-05       Impact factor: 8.322

Review 9.  A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease.

Authors:  Ian A Clark; Bryce Vissel
Journal:  Neural Plast       Date:  2015-07-22       Impact factor: 3.599

Review 10.  The clinical utility of gene expression examination in rheumatology.

Authors:  Elena Tchetina; Galina Markova
Journal:  Mediterr J Rheumatol       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.